Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.


Diz-Kucukkaya R., Hancer V., Inanc M. , Nalcaci M., Pekcelen Y.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102 identifier

  • Cilt numarası: 102
  • Basıldığı Şehir: SAN DIEGO
  • Basıldığı Ülke: CALIFORNIA